BrightGene Bio-Medical Technology Co., Ltd. (SHA: 688166)
China
· Delayed Price · Currency is CNY 30.20
+0.54 (1.82%)
Jan 6, 2025, 4:00 PM CST
BrightGene Bio-Medical Technology Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Cash & Equivalents | 505.36 | 998.05 | 1,180 | 336.84 | 339.53 | 564.97 | Upgrade
|
| Short-Term Investments | - | - | - | - | - | 150 | Upgrade
|
| Trading Asset Securities | - | 50.62 | 50.12 | 0.76 | 180.04 | - | Upgrade
|
| Cash & Short-Term Investments | 505.36 | 1,049 | 1,230 | 337.6 | 519.58 | 714.97 | Upgrade
|
| Cash Growth | -50.41% | -14.78% | 264.48% | -35.02% | -27.33% | 141.18% | Upgrade
|
| Accounts Receivable | 371.79 | 308.88 | 307.47 | 373.85 | 177.27 | 184.69 | Upgrade
|
| Other Receivables | 3.03 | 19.91 | 18.78 | 3.75 | 0.92 | 5.02 | Upgrade
|
| Receivables | 374.82 | 328.79 | 326.25 | 377.59 | 178.19 | 189.7 | Upgrade
|
| Inventory | 339.74 | 344.63 | 280.35 | 200.06 | 203.2 | 136.89 | Upgrade
|
| Prepaid Expenses | - | 3.65 | 5.83 | 4.48 | 5.76 | 0.47 | Upgrade
|
| Other Current Assets | 162.59 | 114 | 95.39 | 73.27 | 39.64 | 20.01 | Upgrade
|
| Total Current Assets | 1,383 | 1,840 | 1,938 | 993.01 | 946.36 | 1,062 | Upgrade
|
| Property, Plant & Equipment | 2,721 | 2,489 | 2,076 | 1,378 | 452.5 | 244.69 | Upgrade
|
| Long-Term Investments | 183.72 | 425.86 | 399.33 | 348.28 | 156.88 | 7.75 | Upgrade
|
| Goodwill | 7.5 | 7.5 | 7.5 | 7.5 | - | - | Upgrade
|
| Other Intangible Assets | 90.83 | 93.66 | 81.64 | 80.84 | 48.76 | 50.05 | Upgrade
|
| Long-Term Deferred Tax Assets | 56.07 | 42.28 | 23.94 | 19.86 | 18.16 | 14.09 | Upgrade
|
| Long-Term Deferred Charges | 37.86 | 30.18 | 26.87 | 25.83 | 33 | 22.91 | Upgrade
|
| Other Long-Term Assets | 399.38 | 104.09 | 107.73 | 115.86 | 172.11 | 19.76 | Upgrade
|
| Total Assets | 4,879 | 5,032 | 4,661 | 2,970 | 1,828 | 1,421 | Upgrade
|
| Accounts Payable | 213.84 | 228.18 | 252.19 | 211.89 | 79.63 | 53.07 | Upgrade
|
| Accrued Expenses | 14.64 | 72.31 | 69.04 | 61.72 | 37.47 | 28.91 | Upgrade
|
| Short-Term Debt | 122.14 | 156.87 | 124.38 | 257.05 | 140.02 | - | Upgrade
|
| Current Portion of Long-Term Debt | 463.61 | 397.93 | 313.87 | 16.58 | 2.56 | - | Upgrade
|
| Current Portion of Leases | - | 16.1 | 1.34 | 9.87 | - | - | Upgrade
|
| Current Income Taxes Payable | 15.97 | 14.04 | 14.97 | 3.69 | 5.44 | 0.59 | Upgrade
|
| Current Unearned Revenue | 28.55 | 24 | 29.49 | 20.33 | 24.82 | - | Upgrade
|
| Other Current Liabilities | 26.73 | 12.81 | 6.26 | 1.93 | 1.78 | 25.64 | Upgrade
|
| Total Current Liabilities | 885.48 | 922.25 | 811.52 | 583.07 | 291.71 | 108.21 | Upgrade
|
| Long-Term Debt | 1,553 | 1,615 | 1,576 | 618.69 | 77.52 | - | Upgrade
|
| Long-Term Leases | 20.05 | 21.01 | 6.01 | 0.22 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 8.5 | 26.25 | 26 | 26 | 26 | - | Upgrade
|
| Other Long-Term Liabilities | 69.55 | 29.82 | - | - | - | - | Upgrade
|
| Total Liabilities | 2,536 | 2,614 | 2,420 | 1,228 | 395.23 | 108.21 | Upgrade
|
| Common Stock | 422.47 | 422.47 | 422.47 | 410 | 410 | 410 | Upgrade
|
| Additional Paid-In Capital | 949.38 | 1,057 | 1,008 | 738.94 | 701.01 | 701.01 | Upgrade
|
| Retained Earnings | 1,035 | 897.66 | 743.35 | 555.05 | 345.54 | 209.28 | Upgrade
|
| Comprehensive Income & Other | -44 | -8.64 | 17.77 | -25.8 | -24.78 | -7.21 | Upgrade
|
| Total Common Equity | 2,352 | 2,369 | 2,192 | 1,678 | 1,432 | 1,313 | Upgrade
|
| Minority Interest | -10.04 | 48.97 | 50.04 | 63.45 | 0.78 | - | Upgrade
|
| Shareholders' Equity | 2,342 | 2,418 | 2,242 | 1,742 | 1,433 | 1,313 | Upgrade
|
| Total Liabilities & Equity | 4,879 | 5,032 | 4,661 | 2,970 | 1,828 | 1,421 | Upgrade
|
| Total Debt | 2,158 | 2,207 | 2,022 | 902.42 | 220.1 | - | Upgrade
|
| Net Cash (Debt) | -1,653 | -1,158 | -791.15 | -564.82 | 299.48 | 714.97 | Upgrade
|
| Net Cash Growth | - | - | - | - | -58.11% | 141.18% | Upgrade
|
| Net Cash Per Share | -3.95 | -2.75 | -1.91 | -1.39 | 0.72 | 1.93 | Upgrade
|
| Filing Date Shares Outstanding | 422.1 | 422.1 | 422.47 | 410 | 410 | 410 | Upgrade
|
| Total Common Shares Outstanding | 422.1 | 422.47 | 422.47 | 410 | 410 | 410 | Upgrade
|
| Working Capital | 497.03 | 917.49 | 1,127 | 409.94 | 654.65 | 953.83 | Upgrade
|
| Book Value Per Share | 5.57 | 5.61 | 5.19 | 4.09 | 3.49 | 3.20 | Upgrade
|
| Tangible Book Value | 2,254 | 2,267 | 2,103 | 1,590 | 1,383 | 1,263 | Upgrade
|
| Tangible Book Value Per Share | 5.34 | 5.37 | 4.98 | 3.88 | 3.37 | 3.08 | Upgrade
|
| Buildings | - | 261.26 | 273.4 | 104.72 | 104.72 | 104.72 | Upgrade
|
| Machinery | - | 704.8 | 318.41 | 287.37 | 253.45 | 219.31 | Upgrade
|
| Construction In Progress | - | 1,736 | 1,666 | 1,131 | 219.14 | 18.2 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.